Position in FBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$145,080
-$619,494 QoQ
Shares Held
52,000
-75.1% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FBIO Over Time
Shares Held
Position Value (USD)
Derivatives in FBIO
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$145,080
PutShares
52,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sculptor Capital LP holds $32,229,273 across 9 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
350,000 | $24,727,500 | |
| 2 | ABCL |
AbCellera Biologics Inc.
|
454,000 | $3,563,900 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
50,000 | $1,935,000 | |
| 4 | BCYC |
Bicycle Therapeutics PLC
|
197,904 | $839,112 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
79,200 | $693,396 | |
| 6 | SLS |
SELLAS Life Sciences Group, Inc.
|
30,300 | $447,228 | |
| 7 | OABI |
OmniAb, Inc.
|
293,802 | $23,137 | |
| 8 | TVGN |
Tevogen Inc.
|
123,600 | $0 |
All Filings in FBIO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $145,080 | 52,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $145,080 | 52,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $764,574 | 208,900 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $773,724 | 211,400 | Put | Defined | 2026-02-13 | |
| 2025-09-30 | $772,930 | 208,900 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $772,930 | 208,900 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||